HealthQuill Inhibitors
Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the Chinese company’s 12 potential medicines.
Drugs Health Pharma

GSK inks $500m deal with Jiangsu Hengrui for 12 potential medicines

HQ Team July 28, 2025: Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the.

Read More
A simple blood test can diagnose Parkinson’s disease which afflicts more than 10 million people globally, according to researchers at the Duke University Health Systems.
Drugs Medical Pharma

Simple blood test can diagnose Parkinson’s Disease at an early stage

HQ Team September 2, 2023: A simple blood test can diagnose Parkinson’s disease which afflicts more than 10 million people globally, according to.

Read More
Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new entity focusing on treating cancers and fibrosis.
Drugs Pharma

Redx, Jounce to merge in a $425 million all-share deal

Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new.

Read More